Atlas Trials

The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma

Clinical trial NCT06863441 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06863441
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
T-NK Cell Lymphoma
Start date
2025-03-01
Primary completion
2029-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.